Demant stock edges higher on UBS target hike
Published on 08/29/2026 at 12:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Demant stock gained a current catalyst on August 20, 2026, when UBS lifted its target price to 300 Danish kroner from 284 and kept a neutral view, according to a MarketScreener consensus page.
Shares last traded at 294.70 Danish kroner on August 28, 2026, leaving the stock 1.8 percent below that target and flat for the day on CBOE tracking data.
Target and trading gap
The gap matters because the new target sits only 5.3 percent above the last close, a narrow spread for a company that still has to convert hearing-care demand into better earnings momentum.
MarketScreener also shows the same page with a 0.00 percent one-day move and a 0.00 percent year-to-date change, which leaves the share price anchored while the broker view shifts.
Latest reported numbers
Demant's most recent full-year report showed revenue of DKK 22.4 billion in 2025, up 4 percent from 2024, with EBIT of DKK 3.2 billion and free cash flow of DKK 1.9 billion. Those figures frame the current debate over whether the company can keep margins moving after a year of moderate top-line growth.
For a fresher operating marker, the latest interim report in 2026 is the key benchmark investors will watch for revenue growth, profitability, and hearing-aid volume trends once the next update lands.
Product pressure
The company's hearing-aid portfolio remains the commercial core, with rechargeable and connected devices driving upgrade cycles in both audiology clinics and retail channels. That business mix matters because small changes in unit volume and pricing can move margin more than a simple revenue headline suggests.
In hearing care, the product story is as important as the broker note.
Stock and market level
Demant shares closed at 294.70 Danish kroner on August 28, 2026, and the stock's latest market reference on August 29, 2026, puts UBS's 300 kroner target within striking distance rather than deep upside territory.
Fact box
Company: Demant A/S
ISIN: DK0010268440
Ticker: DEMANT
Exchange: CBOE tracking data
Price (as of August 28, 2026, 3:55 p.m. BST): DKK 294.70
Sector / Industry: Healthcare / Medical Devices
Index membership: OMX Copenhagen 20
Next earnings date: November 4, 2026
